多巴胺和肠道微生物群:微生物群-肠道-大脑轴内的相互作用和治疗前景
Aurelia Cristiana Barbu1, Smaranda Stoleru1, Aurelian Zugravu1
1Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
International journal of molecular sciences
|January 10, 2026
概括
肠道微生物群影响多巴胺水平和肠-大脑轴中的功能. 这影响了像帕金森病这样的神经系统疾病,并提供了新的治疗点.
科学领域:
- 神经胃肠病学 神经胃肠病学
- 微生物组研究 微生物组研究
- 神经药理学神经药理学
背景情况:
- 微生物群-肠-大脑轴 (MGBA) 涉及复杂的通信通道.
- 多巴胺在中枢神经系统和胃肠道中至关重要.
- 肠道微生物通过特定的酶代谢多巴胺,影响宿主生理.
研究的目的:
- 审查多巴胺-微生物群界面的机制和转化证据.
- 概述影响多巴胺活性的微生物途径.
- 要突出针对这个接口的治疗策略.
主要方法:
- 文献综述综合了当前关于多巴胺-微生物群轴的研究.
- 对参与多巴胺代谢的微生物酶途径的分析.
- 探索翻译证据和治疗机会.
主要成果:
- 肠道微生物群通过氨酸脱氧化酶和甲基醇脱氧化酶等酶显著影响肠道多巴胺代谢.
- 微生物多巴胺代谢与宿主途径竞争,并影响莱沃多巴 (L-DOPA) 疗效.
- 微生物改变的多巴胺信号传递与帕金森病,情绪障碍和其他疾病有关.
结论:
- 多巴胺-微生物群接口是各种神经和系统性疾病的关键因素.
- 微生物群调节,饮食变化和向抑制剂代表了有希望的治疗途径.
- 了解这种相互作用是个性化神经胃肠病学和神经调节治疗的关键.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
412
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
412
Physiology of Enteric Nervous System and Gut Health
856
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
856
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
871
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
871
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928


